Health Predictions
4 sourced future predictions currently published in the Health category. Every prediction rests on a source, a criterion and a probability.
- The First In Vivo CRISPR-Cas9 Gene Editing Therapy, Lonvoguran Ziclumeran (Lonvo-z), Is Expected To Receive US FDA Approval In 2027 For Hereditary Angioedema. 2027
- The Personalized MRNA Cancer Vaccine From Moderna And Merck (Intismeran Combined With Keytruda) Will Receive Its First Approval From A Major Regulator (FDA Or EMA). 2029
- The First Gene Therapy Developed With Base-editing Technology Will Receive Regulatory Approval For Sickle Cell Disease Or Beta Thalassemia. 2032
- AI-assisted Diagnostic Systems Reach Physician-level Performance Across All Medical Imaging 2035